ENT Devices Industry Overview
The global ENT devices market size was valued at USD 20.7 billion in 2020 and is estimated to expand at a compound annual growth (CAGR) of 4.7% from 2021 to 2028. The rising geriatric population, increasing prevalence of ENT-related disorders, increasing penetration of minimally invasive ENT procedures are among the key trends stimulating market growth. Technological advancements also play an important role in the growth of the market.
Demand for advanced ENT devices and systems, such as robot-assisted endoscopes, in developing economies is low due to high cost, as their use is concentrated to developed economies, such as the U.S. However, increasing healthcare spending by other governments and a rise in per capita income are anticipated to significantly improve market penetration. Sales are expected to increase at a rapid pace in developing economies due to the high incidence of ENT diseases, such as hearing loss and sinusitis, and an increase in efforts to provide better access to healthcare facilities in these regions.
Gather more insights about the market drivers, restrains and growth of the Global ENT Devices Market
Hearing loss/impairment has become one of the most common conditions in patients, especially in industrialized countries. According to the WHO, there are over 460 million people worldwide, i.e., around 5% of the world’s population, living with disabling hearing loss, which is expected to increase to over 900 million or 1 in every 10 people by 2050. Two of the main reasons for this are growing life expectancy and increasing noise pollution, which means more cases of age-related hearing loss. Infections such as measles, middle ear infection, or meningitis are also common causes of hearing loss in low-income countries. Moreover, chronic inflammation, noise exposure, vascular disorders, physiological aging of the ear, and genetic susceptibility may cause hearing impairment.
ENT devices for minimally invasive procedures are dominated by companies such as Karl Storz, which offers HD video rhino-laryngoscope that can be used for visualization of nose, pharynx, & larynx in HD image quality. Ambu, Inc. also offers single-use rhino-laryngoscope, which provides ENT specialists an alternative to reusable scopes. In March 2019, the company received CE Mark for Ambu aScope 4 RhinoLaryngo Slim.
Browse through Grand View Research's Medical Devices Industry Research Reports.
• Mammography Market: The global mammography market size was valued at USD 1.95 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 10.26% from 2022 to 2030. The rising prevalence of breast cancer and increasing demand for early-stage diagnosis among patients are some of the key factors anticipated to drive demand for breast cancer diagnostic devices over the forecast period.
• Health Sensors Market: The global health sensors market size was valued at USD 41.18 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 18.53% from 2022 to 2030. The growth is attributed to technological advancements, rising demand for round-the-clock monitoring, increasing demand for health data tracking, and rising incidence of chronic diseases.
ENT Devices Market Segmentation
Grand View Research has segmented the global ENT devices market on the basis of product and region:
ENT Devices Product Outlook(Revenue, USD Million, 2016 - 2028)
• Diagnostic ENT Devices
• Surgical ENT Devices
• Hearing Aids
• Hearing Implants
• Nasal Splints
ENT Devices Regional Outlook(Revenue, USD Million, 2016 - 2028)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)
Key Companies profiled:
Some prominent players in the Global ENT Devices Market include
• Demant A/S
• Sonova
• Ambu A/S
• Pentax Medical
• Karl Storz
• Olympus Corporation
• Richard Wolf Gmbh
• Widex
• Cochlear Ltd.
• Sivantos, Inc.
• Starkey Hearing Technologies
• GN Resound A/S
• Rion Co., Ltd.
• Welch Allyn
• Atos Medical AB
Order a free sample PDF of the ENT Devices Market Intelligence Study, published by Grand View Research.